Bristol-Myers Executive Charged with Inside Trading
Authorities say trades garnered $310,000 in profits.
A Bristol-Myers Squibb executive has been charged with insider trading.
The U.S. attorney's office in Newark, N.J., says Robert Ramnarine bought and sold stock in companies that his pharmaceutical firm was considering buying.
